TGTheun de Groot

Theun de Groot

*This is an algorithmically generated author record based on publicly available information.

Theun de Groot has a total of 178 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    First report of sporotrichosis by Sporothrix brunneoviolacea

    by Mariana Rodrgiues Trápaga, Bram Spruijtenburg, Bruna Jacomel, Jéssica Estefânia Dávila Hidalgo, Karine Ortiz Sanchotene, Fabiana Fedatto Bernardon, Bruna Muradás Esperon, Vanice Rodrigues Poester, Theun de Groot, Eelco F.J. Meijer, et al.

  • Open Access

    The rise of Candidozyma auris in Czechia: three clades, prosthetic joint infection and fluconazole resistance development, 2022 to 2024

    by Bram Spruijtenburg, Jacques F Meis, Norman van Rhijn, Martina Čurdová, Eva Kašperová, Petr Vašek, Lucie Bartoníčková, Jan Kubele, Petra Olišarová, Kateřina Svobodová, et al.

    BACKGROUND: Candidozyma auris has emerged globally as a major threat to public health due to its outbreak causing capacity and antifungal resistance. Outbreaks have proven difficult to control despite enhanced infection prevention measures. Thus, national surveillance is warranted. AIM: We aim to characterise the epidemiology of C. auris cases in Czechia between 2022 and 2024 to investigate whether autochthonous spread is occurring and asses antifungal resistance. METHODS: High-resolution genotyping was performed to assess genetic relatedness between isolates. Microbroth dilution was performed on all isolates and underlying mechanisms resistance were inspected with whole genome sequencing. RESULTS: Eight cases from seven different hospitals were reported, mainly collected from non-sterile sites, in addition to the first documented prosthetic joint infection by C. auris . Only two patients reported travel history. Three clades were found, with the first report of Clade IV in Europe. For one patient, initial isolates were pan-susceptible but after short exposure to fluconazole became resistant with a novel mechanism. CONCLUSION: C. auris reported in Czechia in patients without travel history suggests autochthonous spread. Three clades were present, often with unknown route of introduction. Development of fluconazole resistance upon brief exposure highlights the ability of C. auris to rapidly evolve.


  • Open Access

    Genetic Epidemiology and Resistance Investigations of Clinical Yeasts in Alexandria, Egypt

    by Bram Spruijtenburg, Carolina Melchior Do Prado, Mats van Kempen, Sherine M. Shawky, Jacques F. Meis, Vânia Aparecida Vicente, Flavio Queiroz-Telles, Theun de Groot, Mohammed A. El-Kholy, Eelco F. J. Meijer

    Yeast bloodstream infections lead to high mortality and morbidity and are mostly observed in immunocompromised patients. In Africa, only a few studies have characterized clinical yeasts. To increase insight into yeast resistance and transmission in Africa, we identified various yeasts from Alexandria, Egypt and performed antifungal susceptibility testing (AFST) and genotyping. A total of 1307 single isolates from unique patients, recovered from different anatomical sites including the bloodstream, retrieved from a reference laboratory in Alexandria, Egypt were studied. All isolates were identified with MALDI-TOF MS, while some were initially identified with a Vitek 2 Compact system. Short tandem repeat (STR) genotyping was performed for the most common species, and AFST was performed with microbroth dilution. Among bloodstream isolates (n = 71), C. albicans was the most common etiological agent, followed by C. tropicalis and C. parapsilosis. Comparison of yeast identification methods demonstrated that 22% of isolates were incorrectly identified with the Vitek 2 Compact system compared to MALDI-TOF MS. Multiple rare yeasts showed reduced antifungal susceptibility. STR genotyping demonstrated potential events of nosocomial transmission with N. glabratus and C. parapsilosis. Moreover, an azole-resistant C. tropicalis clade identified earlier in Alexandria was still present. To conclude, clinical yeasts in Alexandria, Egypt, are overall susceptible common species.


  • Open Access

    Clonal outbreak of Candida vulturna in a paediatric oncology ward in Maranhão, Brazil

    by Alessandra Teixeira de Macedo, Daniel Wagner de Castro Lima Santos, Bram Spruijtenburg, Dayse Azevedo Coelho de Souza, Leila Ferreira Moreira dos Santos Barbosa, Sirlei Garcia Marques, Julliana Ribeiro Alves dos Santos, Eelco F.J. Meijer, Theun de Groot, Conceição de Maria Pedrozo e Silva de Azevedo, et al.


  • Open Access

    Epidemiology of Candidemia in Mashhad, Northeast Iran: A Prospective Multicenter Study (2019–2021)

    by Somayeh Dolatabadi, Mohammad Javad Najafzadeh, Abbas Raeisabadi, Hossein Zarrinfar, Mahsa Jalali, Bram Spruijtenburg, Eelco F. J. Meijer, Jacques F. Meis, Cornelia Lass-Flörl, Theun de Groot

    Candidemia is a major cause of morbidity and mortality in health care settings, and its epidemiology is changing. In the last two decades, the proportion of non-albicans Candida (NAC) yeasts in candidemia has increased. These yeasts more often display resistance to common antifungals. In many western countries, candidemia is mainly caused by susceptible C. albicans, while in resource-limited countries, including Iran, the candidemia species distribution is studied less often. Here, we investigated the species distribution, resistance levels, and characteristics of patients with candidemia in five hospitals in Mashhad (northeast Iran) for two years (2019–2021). Yeast isolates from blood were identified with MALDI-TOF MS and subjected to antifungal susceptibility testing (AFST) using the broth microdilution method, while molecular genotyping was applied to Candida parapsilosis isolates. In total, 160 yeast isolates were recovered from 160 patients, of which the majority were adults (60%). Candidemia was almost equally detected in men (48%) and women (52%). Almost half of patients (n = 67, 49%) were from intensive care units (ICUs). C. parapsilosis (n = 58, 36%) was the most common causative agent, surpassing C. albicans (n = 52, 33%). The all-cause mortality rate was 53%, with C. albicans candidemia displaying the lowest mortality with 39%, in contrast to a mortality rate of 59% for NAC candidemia. With microbroth AFST, nearly all tested isolates were found to be susceptible, except for one C. albicans isolate that was resistant to anidulafungin. By applying short tandem repeat (STR) genotyping to C. parapsilosis, multiple clusters were found. To summarize, candidemia in Mashhad, Iran, from 2019 to 2021, is characterized by common yeast species, in particular C. parapsilosis, for which STR typing indicates potential nosocomial transmission. The overall mortality is high, while resistance rates were found to be low, suggesting that the high mortality is linked to limited diagnostic options and insufficient medical care, including the restricted use of echinocandins as the first treatment option.


  • Open Access

    Susceptibility Testing of Environmental and Clinical Aspergillus sydowii Demonstrates Potent Activity of Various Antifungals

    by Bram Spruijtenburg, Antonio Rezusta, Jos Houbraken, Ferry Hagen, Theun de Groot, Jacques F. Meis, Eelco F. J. Meijer

    The genus Aspergillus consists of a vast number of medically and environmentally relevant species. Aspergillus species classified in series Versicolores are ubiquitous in the environment and include the opportunistic pathogen Aspergillus sydowii, which is associated with onychomycosis and superficial skin infections. Despite frequent clinical reports of A. sydowii and related series Versicolores species, antifungal susceptibility data are scarce, hampering optimal treatment choices and subsequent patient outcomes. Here, we employed antifungal susceptibility testing (AFST) based on microbroth dilution on a set of 155 series Versicolores strains using the common antifungals amphotericin B, itraconazole, voriconazole, posaconazole, isavuconazole and micafungin with the addition of luliconazole and olorofim. All strains were identified using partial calmodulin gene sequencing, with 145 being A. sydowii, seven A. creber and three A. versicolor, using the latest taxonomic insights. Overall, tested antifungals were potent against the entire strain collection. In comparison to A. fumigatus, azole and amphotericin B MICs were slightly elevated for some strains. AFST with luliconazole and olorofim, here reported for the first time, displayed the highest in vitro activity, making these antifungals interesting alternative drugs but clinical studies are warranted for future therapeutic use.


  • Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil

    by Bram Spruijtenburg, João Nobrega de Almeida Júnior, Felipe de Camargo Ribeiro, Karoline Kristina Kemmerich, Karla Baeta, Eelco F. J. Meijer, Theun de Groot, Jacques F. Meis, Arnaldo Lopes Colombo, Brazilian Candida auris collaborative network

    Background: Candida auris is an emerging multidrug‐resistant yeast, frequently causing outbreaks in health care facilities. The pathogen persistently colonises human skin and inanimate surfaces such as catheters, aiding to its spread. Moreover, colonisation is a risk factor to develop invasive infection.Objectives: We investigated 61 C. auris strains isolated from non‐sterile human body sites (n = 53) and the hospital environment (n = 8), originating from four different centres in a single Brazilian state.Materials and Methods: Antifungal susceptibility testing (AFST) against common antifungals was performed, and resistance‐associated genes were evaluated. Genetic relatedness was investigated with short tandem repeat (STR) genotyping and validated with whole‐genome sequencing (WGS) single nucleotide polymorphism (SNP) analysis.Results: Antifungal susceptibility testing demonstrated that all isolates were susceptible to azoles, echinocandins and amphotericin B. No mutations were detected in ERG11 and FKS1 genes. With STR typing, isolates were allocated to clade IV and appeared closely related. This was confirmed by WGS SNP analysis of 6 isolates, which demonstrated a maximal difference of only 41 SNPs between these strains. Furthermore, the Brazilian isolates formed a distinct autochthonous branch within clade IV, excluding recent introductions from outside the country. A molecular clock analysis of clade IV isolates from various countries suggests that early in the previous century there was a unique event causing environmental spread of a C. auris ancestor throughout the Latin‐American continent, followed by human introduction during the last decades.Conclusion: We report the emergence of C. auris patient colonisation in multiple centres by fluconazole‐susceptible clade IV close‐related strains in Pernambuco State, Brazil.


  • Open Access

    The yeast genus Tardiomyces gen. nov. with one new species and two new combinations

    by Bram Spruijtenburg, Bruna Jacomel Favoreto de Souza Lima, Sonia T. Granadillo Tosar, Andrew M. Borman, Cecilie Torp Andersen, Summiya Nizamuddin, Suhail Ahmad, João Nobrega de Almeida Junior, Vânia Aparecida Vicente, Joshua D. Nosanchuk, et al.

    Purpose: Rare yeasts species are increasingly reported as causative agents of invasive human infection. Proper identification and antifungal therapy are essential to manage these infections. Candida blankii is one of these emerging pathogens and is known for its reduced susceptibility to multiple antifungals. Methods: To obtain more insight into the characteristics of this species, 26 isolates reported as C. blankii were investigated using genetic and phenotypical approaches. Results: Among the 26 isolates, seven recovered either from blood, sputum, urine, or the oral cavity, displayed substantial genetic and some phenotypical differences compared to the other isolates, which were confirmed as C. blankii. We consider these seven strains to represent a novel species, Tardiomyces depauwii. Phylogenomics assigned C. blankii, C. digboiensis, and the novel species in a distinct branch within the order Dipodascales, for which the novel genus Tardiomyces is erected. The new combinations Tardiomyces blankii and Tardiomyces digboiensis are introduced. Differences with related, strictly environmental genera Sugiyamaella, Crinitomyces, and Diddensiella are enumerated. All three Tardiomyces species share the rare ability to grow up to 42 °C, display slower growth in nutrient-poor media, and show a reduced susceptibility to azoles and echinocandins. Characteristics of T. depauwii include high MIC values with voriconazole and a unique protein pattern. Conclusion: We propose the novel yeast species Tardiomyces depauwii and the transfer of C. blankii and C. digboiensis to the novel Tardiomyces genus.


  • Molecular typing and antifungal susceptibility profile of Candida krusei bloodstream isolates from Türkiye

    by Ayşe Sultan Karakoyun, Bram Spruijtenburg, Nevzat Unal, Eelco F J Meijer, Mete Sucu, Süleyha Hilmioğlu-Polat, Jacques F Meis, Theun de Groot, Macit Ilkit

    Candida krusei also known as Pichia kudriavzevii is a potentially multidrug-resistant yeast because it is intrinsically resistant to fluconazole and develops acquired resistance to echinocandins and polyenes. Here, we aim to provide a better understanding of the epidemiology and transmission modes of C. krusei infections by comparing invasive bloodstream (n = 35) and non-invasive vaginal (n = 20) C. krusei isolates. The genetic relatedness of the isolates was assessed using a newly described short tandem repeat (STR) analysis and their sensitivity to eight antifungal compounds was evaluated by antifungal susceptibility testing using the CLSI microbroth dilution method. All C. krusei isolates revealed unique STR genotypes, indicating the absence of clonal transmission in the study group. Furthermore, no drug-resistant or non-wild-type isolates were identified. Our findings demonstrated high resolution of STR genotyping for the detection and simultaneous genetic analysis of multiple C. krusei strains in clinical samples and excellent in vitro activity of common antifungal agents against invasive strains. To gain insight into the mode of transmission and resistance development of C. krusei, we compared invasive bloodstream C. krusei isolates with non-invasive vaginal isolates using genotyping and susceptibility testing. All isolates demonstrated unique genotypes and no antifungal resistance was found, indicating the absence of clonal transmission and a high susceptibility to antifungals.


  • Open Access

    An Autochthonous Susceptible Candida auris Clade I Otomycosis Case in Iran

    by Bahram Ahmadi, Behrouz Naeimi, Mohammad Javad Ahmadipour, Hamid Morovati, Theun de Groot, Bram Spruijtenburg, Hamid Badali, Jacques F. Meis

    Candida auris is a newly emerging multidrug-resistant fungal pathogen considered to be a serious global health threat. Due to diagnostic challenges, there is no precise estimate for the prevalence rate of this pathogen in Iran. Since 2019, only six culture-proven C. auris cases have been reported from Iran, of which, five belonged to clade V and one to clade I. Herein, we report a case of otomycosis due to C. auris from 2017 in a 78-year-old man with diabetes mellitus type II without an epidemiological link to other cases or travel history. Short tandem repeat genotyping and whole genome sequencing (WGS) analysis revealed that this isolate belonged to clade I of C. auris (South Asian Clade). The WGS single nucleotide polymorphism calling demonstrated that the C. auris isolate from 2017 is not related to a previously reported clade I isolate from Iran. The presence of this retrospectively recognized clade I isolate also suggests an early introduction from other regions or an autochthonous presence. Although the majority of reported C. auris isolates worldwide are resistant to fluconazole and, to a lesser extent, to echinocandins and amphotericin B, the reported clade I isolate from Iran was susceptible to all antifungal drugs.